ATNM
Actinium Pharmaceuticals, Inc.Verdict
We can't put a fair value on ATNM right now. We haven't analysed this company yet.
Follow ATNM
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 2, 2026: no open-market purchases and 13 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
Chell Jeffrey W.
director · 2026-09-02
Award
$92K
Chell Jeffrey W.
director · 2026-09-02
Award
61,600 shares
Steinhart Richard I
director · 2026-09-02
Award
$94K
Steinhart Richard I
director · 2026-09-02
Award
62,800 shares
SETH SANDESH
Chief Executive Officer · 2026-09-02
Award
$1.1M
Show all 13 other filingsShow fewer
SETH SANDESH
Chief Executive Officer · 2026-09-02
Award
1,027,274 shares
SETH SANDESH
Chief Executive Officer · 2026-09-02
Award
753,600 shares
Almenoff June Sherie
director · 2026-09-02
Award
$27K
Almenoff June Sherie
director · 2026-09-02
Award
18,000 shares
Nicholson, C. David
director · 2026-09-02
Award
$94K
Nicholson, C. David
director · 2026-09-02
Award
62,800 shares
Shetty Ajit
director · 2026-09-02
Award
$92K
Shetty Ajit
director · 2026-09-02
Award
61,600 shares
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. How the Payback Price works